{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T14:19:07Z","timestamp":1770733147788,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T00:00:00Z","timestamp":1231459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00192-008-0782-9","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T17:20:33Z","timestamp":1231435233000},"page":"381-385","source":"Crossref","is-referenced-by-count":21,"title":["Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6\u00a0months"],"prefix":"10.1007","volume":"20","author":[{"given":"Rebecca G.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tola","family":"Omotosho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franklin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon D.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,9]]},"reference":[{"key":"782_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/nau.20251","volume":"25","author":"P Abrams","year":"2006","unstructured":"Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P (2006) Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn 25:293","journal-title":"Neurourol Urodyn"},{"key":"782_CR2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein A (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327\u2013336","journal-title":"World J Urol"},{"key":"782_CR3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306\u20131315","journal-title":"Eur Urol"},{"key":"782_CR4","first-page":"S580","volume":"6","author":"P Abrams","year":"2000","unstructured":"Abrams P, Kellecher CJ, Kerr LA, Rogers RG (2000) Overactive bladder significantly affects quality of life. Am J Manag Care 6:S580\u2013S590","journal-title":"Am J Manag Care"},{"key":"782_CR5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1743-6109.2007.00493.x","volume":"4","author":"KS Coyne","year":"2007","unstructured":"Coyne KS, Margolis MK, Jumadilova Z, Bavendam T, Mueller E, Rogers R (2007) Overactive bladder and women\u2019s sexual health: what is the impact? J Sex Med 4:656\u2013666","journal-title":"J Sex Med"},{"key":"782_CR6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","volume":"57","author":"P Kerrebroeck Van","year":"2001","unstructured":"Van Kerrebroeck P, Kreder K, Jonas U et al (2001) Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology 57:414\u2013421","journal-title":"Urology"},{"key":"782_CR7","doi-asserted-by":"crossref","unstructured":"Rogers R, Bachmann G, Jumadilova Z, Sun F, Morrow JD, Guan Z, Bavendam T (2008) Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women. Int J Urogynecol Pelvic Floor Dysfunct 19:1551\u20131557","DOI":"10.1007\/s00192-008-0688-6"},{"key":"782_CR8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0302-2838(02)00177-X","volume":"41","author":"K Kreder","year":"2002","unstructured":"Kreder K, Mayne C, Jonas U (2002) Long-term tolerability and efficacy and extended-release tolterodine in the treatment of overactive bladder. Eur Urol 41:588\u2013595","journal-title":"Eur Urol"},{"key":"782_CR9","first-page":"S616","volume":"8","author":"CJ Kelleher","year":"2002","unstructured":"Kelleher CJ, Kreder KJ, Pleil AM et al (2002) Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 8:S616\u2013S630","journal-title":"Am J Manag Care"},{"key":"782_CR10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","volume":"49","author":"KS Coyne","year":"2006","unstructured":"Coyne KS, Matza LS, Kopp Z et al (2006) The validation of the Patient Perception of Bladder Condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol 49:1079\u20131086","journal-title":"Eur Urol"},{"key":"782_CR11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1016370925601","volume":"11","author":"K Coyne","year":"2002","unstructured":"Coyne K, Revicki D, Hunt T et al (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11:563\u2013574","journal-title":"Qual Life Res"},{"key":"782_CR12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/mob.2001.111100","volume":"184","author":"RG Rogers","year":"2001","unstructured":"Rogers RG, Kammerer-Doak D, Villarreal A, Coates K, Qualls C (2001) A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse. Am J Obstet Gynecol 184:552\u2013558","journal-title":"Am J Obstet Gynecol"},{"key":"782_CR13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00926230591006502","volume":"31","author":"T Symonds","year":"2005","unstructured":"Symonds T, Boolell M, Quirk F (2005) Development of a questionnaire on sexual quality of life in women. J Sex Marital Ther 31:385\u2013397","journal-title":"J Sex Marital Ther"},{"key":"782_CR14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"782_CR15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2006.09.021","volume":"195","author":"RG Rogers","year":"2006","unstructured":"Rogers RG, Kammerer-Doak D, Darrow A, Murray K, Olsen A, Barber M, Qualls C (2006) Does sexual function change after surgery for stress urinary incontinence and\/or pelvic organ prolapse: a multi-center prospective study. Am J Obstet Gynecol Nov 195(5):e1\u20134","journal-title":"Am J Obstet Gynecol Nov"},{"key":"782_CR16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajog.2003.10.709","volume":"190","author":"K Baessler","year":"2004","unstructured":"Baessler K, Stanton SL (2004) Does Burch colposuspension cure coital incontinence? Am J Obstet Gynecol 190:1030\u20131033","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"782_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.18553\/jmcp.2008.14.3.291","volume":"14","author":"AO D\u2019Souza","year":"2008","unstructured":"D\u2019Souza AO, Smith MJ, Miller LA, Doyle J, Ariely R (2008) Persistence, adherence and switch rates among extended release overactive bladder medications in a regional managed care plan. J Manag Care Pharm 14(3):291\u2013301","journal-title":"J Manag Care Pharm"},{"key":"782_CR18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1464-410X.2008.07769.x","volume":"102","author":"RK Basra","year":"2008","unstructured":"Basra RK, Wagg A, Chapple C, Cardozo L, Castro-Diaz D, Pons ME et al (2008) A review of adherence to drug therapy in patients with overactive bladder. BJU Int 102:774\u2013779","journal-title":"BJU Int"},{"issue":"11","key":"782_CR19","first-page":"S599","volume":"6","author":"JG Ouslander","year":"2000","unstructured":"Ouslander JG, Shih YT, Malone-Lee J, Luber K (2000) Overactive bladder: special considerations in the geriatric population. Am J Manag Care 6(11):S599\u2013S606","journal-title":"Am J Manag Care"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-008-0782-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-008-0782-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-008-0782-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T16:43:32Z","timestamp":1632933812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-008-0782-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,9]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1007\/s00192-008-0782-9","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,9]]}}}